Mountain View, CA, United States of America

Andrew Trans

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Mt. View, CA (US) (2016 - 2019)
  • Mountain View, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2016-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):

Title: The Innovative Mind of Andrew Trans

Introduction

Andrew Trans, based in Mountain View, CA, is a remarkable inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 11 patents, he has made strides in advancing biochip technology and nucleic acid sequencing.

Latest Patents

Trans's latest patents showcase his innovative thinking and technical prowess. One notable patent is titled "Methods for Forming Lipid Bilayers on Biochips." This invention describes a biochip that includes multiple wells, each featuring a membrane with a nanopore, which enables the detection of ionic flow resulting from species interacting with the nanopore. The design integrates a lipid bilayer formed using bubbles, which enhances the functionality of the biochip.

Another significant patent he holds is "Polypeptide Tagged Nucleotides and Use Thereof in Nucleic Acid Sequencing by Nanopore Detection." This disclosure presents unique compositions and methodologies that revolve around the use of polypeptide-tagged nucleotides in nanopore devices, further pushing the boundaries of genetic sequencing technologies.

Career Highlights

Throughout his career, Andrew Trans has collaborated with notable companies in the biotechnology sector, including Roche Sequencing Solutions, Inc. and Genia Technologies, Inc. His work is recognized for blending innovative concepts with practical applications, driving advancements that have a far-reaching impact on the industry.

Collaborations

Trans has been fortunate to work alongside talented professionals such as Edward Shian Liu and Eric Takeshi Harada. These collaborations have been instrumental in crafting pioneering solutions and expanding the horizons of what is possible in genetic sequencing and bioengineering.

Conclusion

Andrew Trans stands out as a significant figure in the realm of biotechnology innovations. His 11 patents reflect a deep commitment to excellence and a relentless pursuit of new methodologies that address complex biological challenges. As he continues to innovate, Trans undoubtedly paves the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…